関連する実験動画
Updated: Aug 9, 2026

12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
I型糖尿病におけるコンプリメント固定小島細胞抗体:活性ベータ細胞損傷の可能なモニター
Lancet (London, England)
|March 29, 1980
まとめ
補足固定小島細胞抗体は1型糖尿病の発症とベータ細胞損傷に関連しています. これらの抗体は,従来の小島細胞抗体よりも,タイプ1糖尿病の進行を研究するためのより良いマーカーである可能性があります.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 糖尿病学 糖尿病学
背景:
- 1型糖尿病は,臓のβ細胞の破壊によって特徴づけられる自己免疫疾患です.
- 島細胞抗体は1型糖尿病のマーカーとして使用されていますが,その正確な役割と予測価値はまだ調査中です.
研究 の 目的:
- コンプリメントを固定する小島細胞抗体の存在と重要性を調査する.
- 1型糖尿病におけるコンプレメント固定小島細胞抗体と従来の小島細胞抗体の臨床的関連性を比較する.
主な方法:
- 1型糖尿病患者,非糖尿病の多分泌患者,および1型糖尿病患者の親族からの血清サンプルを分析した.
- コンプリメントを固定する小島細胞抗体と従来の小島細胞抗体の測定.
主要な成果:
- 補完体を固定する小島細胞抗体の異なる種の証拠が見つかりました.
- 補足固定小島細胞抗体は,臨床疾患の発症とより強い関連性を示し,従来の抗体よりも早く消失した.
- これらの抗体は,選択的に臓β細胞の損傷を示す可能性があります.
結論:
- コンプリメントを固定する小島細胞抗体は,ベータ細胞の損傷を潜在的に反映する異なる実体を表します.
- 伝統的な小島細胞抗体と比較して,タイプ1糖尿病の自然経歴を研究するための優れた血清学的マーカーとして機能する可能性があります.
関連する概念動画
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

